Ansag, Robinson S.
HRN: 21-59-86 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/21/2022
CIPROFLOXACIN 500MG (TAB)
07/21/2022
07/27/2022
ORAL
500mg/tab
BID
Pyelonephritis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes